203
Views
26
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Cytokine gene polymorphisms in Turkish patients with inflammatory bowel disease

, , , , , , , , , & , MD PhD show all
Pages 559-565 | Received 25 May 2005, Published online: 26 Aug 2009

References

  • Bonen DK, Cho JH. The genetics of inflammatory bowel disease. Gastroenterology 2003; 124: 524–36
  • Heresbach D, Alizadeh M, Dabadie A, Le Berre N, Colombel JF, Yaouanq J, et al. Significance of interleukin-1β and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel disease. Am J Gastroenterol 1997; 92: 1164–9
  • Schreiber S. Inflammatory bowel disease: immunologic concepts. Hepatogastroenterology 2000; 47: 15–28
  • Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D. Role of IL-1 in inflammatory bowel disease: enhanced production during active disease. Gut 1990; 31: 686–9
  • Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, Macdemott RP, et al. Enhanced secretion of TNFα, IL-6 and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94: 174–81
  • Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, et al. Localisation of intestinal IL-1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993; 104: 749–58
  • Dionne S, Hiscott J, D'Agata I. Quantitative PCR analysis of TNF-α and IL1B mRNA levels in pediatric inflammatory bowel disease mucosal biopsies. Dig Dis Sci 1997; 42: 1557–66
  • Stack WA, Mann SD, Roy AJ. Randomised controlled trial of CDP571 antibody to TNFα for Crohn's disease. Lancet 1997; 349: 521–4
  • Targan SR, Hanover SB, von Deventer SJ. A short-term study of chimeric monoclonal antibody cA2 to TNFα for Crohn's disease. N Engl J Med 1997; 337: 1029–35
  • Casini-Raggi V, Kam L, Chong YJ, Fiocchi C, Pizarro TT, Cominelli F. Mucosal imbalance of IL-1 and IL-1RN in inflammatory bowel disease: a novel mechanism of chronic intestinal inflammation. J Immunol 1995; 154: 2434–40
  • Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse T helper cell. IV. TH2 clones secrete a factor that inhibits cytokine production by TH1 clones. J Exp Med 1989; 70: 2081–95
  • Schreiber S, Heinig T, Thiele HG, Raedler A. Immunoregulatory role of IL-10 in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 1434–44
  • Aljanabi SM, Martinez I. Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques. Nucleic Acids Res 1997; 25: 4692–3
  • Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkassarer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 bp. tandem repeat. Hum Genet 1993; 91: 403–4
  • Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL, Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106: 637–42
  • Reynard MP, Turner D, Navarrete CV. Allele frequencies of polymorphisms of the TNFα, IL-10, interferon-gamma, and IL-2 genes in a North European Caucosoid group from the UK. Eur J Immunogenet 2000; 27: 241–9
  • Day CP, Groove J, Daly AK, Stewart MW, Avery PJ, Walker M. TNFα gene promoter polymorphism and decreased insulin resistance. Diabetologia 1998; 41: 430–4
  • Edwards-Smith CJ, Jonnson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. IL-10 promoter polymorphism predicts initial response of chronic hepatitis C interferon alfa. Hepatology 1999; 30: 526–30
  • Aithal GP, Craggs A, Day C, Welfare M, Dally A, Mansfield JC, et al. Role of polymorphisms in the interleukin-10 gene in determining disease susceptibility and phenotype in inflammatory bowel disease. Dig Dis Sci 2001; 46: 1520–5
  • Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, et al. TNF gene polymorphism influences TNFα production in LPS stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401–6
  • Gonzalez S, Rodrigo L, Martinez Borra J, Lopez-Vazquez A, Fuentez D, Nino P, et al. TNF-α-308A promoter polymorphism is associated with enhanced TNFα production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 2003; 98: 1101–6
  • Sashio H, Tamura K, Ito R, Yamamota Y, Bamba H, Kosaka T, et al. Poymorphisms of TNF gene and the TNF receptor superfamily member 1B gene are associated with susceptibility to ulcerative colitis and Crohn's disease, respectively. Immunogenetics 2002; 53: 1020–7
  • Balding J, Livingstone WJ, Conroy J, Johnson LM, Weir DG, Mahmudi N, et al. Inflammatory bowel disease: the role of inflammatory cytokine gene polymorphisms. Mediators Inflamm 2004; 13: 181–7
  • Vatay A, Bene L, Kovacs A, Phohaszka Z, Szalai C, Romics L, et al. Relationship between TNFα polymorphism and the serum C-reactive protein levels in inflammatory bowel disease. Immunogenetics 2003; 55: 247–52
  • Louis E, Satsangi J, Roussomoustakaki M, Parkes M, Fanning G, Welsh K, et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996; 39: 705–10
  • Bouma G, Crusius JBA, Garcia Gonzalez MA, Meijer BU, Hellemens HP, Hakvoort RJ, et al. Genetic markers in clinically well-defined patients with ulcerative colitis. Clin Exp Immunol 1999; 115: 294–300
  • Wilkinson RJ, Patel P, Lweln M. Influence on polymorphism in the genes for the interleukin-1 receptor antagonist and IL-1B on tuberculosis. J Exp Med 1999; 189: 1863–73
  • Tountas NA, Casini-Raggi V, Yang H, Giovine FS, Vecchi M, Kam L, et al. Functional and ethnic association af allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology 1999; 117: 806–13
  • Mwantembe O, Gaillard MC, Barkhuizen M. Ethnic differences in allelic associations of the interleukin-1 gene cluster in South African patients with inflammatory bowel disease and in control individuals. Immunogenetics 2001; 52: 249–54
  • Craggs A, West S, Curtis A, Welfare M, Hudson M, Donaldson P, et al. Absence of genetic association between IL-1RN and IL-1B gene polymorphisms in ulcerative colitis and Crohn's disease in multiple populations from Northeast England. Scand J Gastroenterol 2001; 11: 1173–8
  • Hacker UT, Gomolka M, Keller E, Eigler A, Folwaczny C, Fricke H, et al. Lack of association between an IL-1RN gene polymorphism and ulcerative colitis. Gut 1997; 40: 623–7
  • Bioque G, Crusius JB, Koutroubakis I, Bouma G, Kostense PJ, Muwissen SG, et al. Allelic polymorphism in IL-1B and IL-1 receptor antagonist genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379–83
  • Carter MJ, Jones S, Camp NJ, Cox A, Mee J, Warren B, et al. Functional correlates of the IL-1 receptor antagonist gene polymorphism in the colonic mucosa in ulcerative colitis. Genes Immun 2004; 5: 8–15
  • Nemetz A, Escanilla MPN, Molnar T, Kope A, Kovacs A, Feher J, et al. IL-1β polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 1999; 49: 527–31
  • Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller V. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75: 263–74
  • Crawley E, Kay R, Silibourne J, Patel P, Hutchison I, Woo P. Polymorphic haplotypes of the IL-10 flanking region determine variable IL-10 transcription and associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum 1999; 42: 1101–8
  • Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the IL10 gene promoter. Eur J Immunogenet 1997; 24: 1–8
  • Klein W, Tromm A, Griga T, Fricke H, Folwaczny C, Hocke M, et al. The IL-10 gene is not involved in the predisposition to inflammatory bowel disease. Electrophoresis 2000; 21: 3578–82
  • Tagore A, Gonsalkorale WM, Pravica V, Hajeer AH, Mcmahon R, Whorwell PJ, et al. Interleukin-10 (IL-10) genotypes in inflammatory bowel disease. Tissue Antigens 1999; 54: 386–90
  • Duer RH, Barmadfa MM, Zhang L, Davis S, Preston RA, Chensny LJ, et al. Linkage and association between inflammatory bowel disease and a locus on chromosome 12. Am J Hum Genet 1998; 63: 95–100
  • Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996; 379: 821–3
  • Rioux JD, Silverberg MS, Daly MJ, Steinhart AH, McLeod RS, Griffiths AM, et al. Genome wide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet 2000; 66: 1863–70
  • Satsangi J, Parkes M, Louis E, Hashimoto L, Kato N, Welsh K, et al. Two-stage genome wide searches in inflammatory bowel disease provide evidence for susceptibility loci on chromosomes 3, 7, 12. Nat Genet 1996; 14: 199–202

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.